Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial

Purpose Myocardial dysfunction is common in sepsis but optimal treatment strategies are unclear. The inodilator, levosimendan was suggested as a possible therapy; however, the levosimendan to prevent acute organ dysfunction in Sepsis (LeoPARDS) trial found it to have no benefit in reducing organ dys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Intensive care medicine 2019-10, Vol.45 (10), p.1392-1400
Hauptverfasser: Antcliffe, David B., Santhakumaran, Shalini, Orme, Robert M. L., Ward, Josie K., Al-Beidh, Farah, O’Dea, Kieran, Perkins, Gavin D., Singer, Mervyn, McAuley, Daniel F., Mason, Alexina J., Cross, Mary, Ashby, Deborah, Gordon, Anthony C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!